APA

Eefting D., de Vries M. R., Grimbergen J. M., Karper J. C., van Bockel J. H. & Quax P. H. A. (20100304). In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. : Journal of vascular surgery.

Chicago

Eefting Daniel, de Vries Margreet R, Grimbergen Jos M, Karper Jacco C, van Bockel J Hajo and Quax Paul H A. 20100304. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. : Journal of vascular surgery.

Harvard

Eefting D., de Vries M. R., Grimbergen J. M., Karper J. C., van Bockel J. H. and Quax P. H. A. (20100304). In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. : Journal of vascular surgery.

MLA

Eefting Daniel, de Vries Margreet R, Grimbergen Jos M, Karper Jacco C, van Bockel J Hajo and Quax Paul H A. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. : Journal of vascular surgery. 20100304.